[1]
L. C. Price, “Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 41, no. 1, p. e2024024, Mar. 2024, doi: 10.36141/svdld.v41i1.15515.